Proteome Sciences PMSNF Stock
Proteome Sciences Price Chart
Proteome Sciences PMSNF Financial and Trading Overview
| Proteome Sciences stock price | 0.0100 USD |
| Previous Close | 0.01 USD |
| Open | 0.01 USD |
| Bid | 0.01 USD x 1000000 |
| Ask | 0.04 USD x 1000000 |
| Day's Range | 0.01 - 0.01 USD |
| 52 Week Range | 0.01 - 0.05 USD |
| Volume | 4K USD |
| Avg. Volume | 925 USD |
| Market Cap | 3.51M USD |
| Beta (5Y Monthly) | 0.143 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PMSNF Valuation Measures
| Enterprise Value | 18.92M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.9337724 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 5.037 |
| Enterprise Value/EBITDA | -7.609 |
Trading Information
Proteome Sciences Stock Price History
| Beta (5Y Monthly) | 0.143 |
| 52-Week Change | -80.00000000000000000000000000000000% |
| S&P500 52-Week Change | 15.30% |
| 52 Week High | 0.05 USD |
| 52 Week Low | 0.01 USD |
| 50-Day Moving Average | 0.02 USD |
| 200-Day Moving Average | 0.03 USD |
PMSNF Share Statistics
| Avg. Volume (3 month) | 925 USD |
| Avg. Daily Volume (10-Days) | 100 USD |
| Shares Outstanding | 350.72M |
| Float | 225.08M |
| Short Ratio | N/A |
| % Held by Insiders | 18.08% |
| % Held by Institutions | 24.21% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | December 31, 2025 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -81.49% |
| Operating Margin (ttm) | -54.97% |
| Gross Margin | -2.15% |
| EBITDA Margin | -66.18% |
Management Effectiveness
| Return on Assets (ttm) | -19.19% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 3.76M USD |
| Revenue Per Share (ttm) | 0.01 USD |
| Quarterly Revenue Growth (yoy) | -28.89% |
| Gross Profit (ttm) | -81000 USD |
| EBITDA | -2486000 USD |
| Net Income Avi to Common (ttm) | -3061000 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 781K USD |
| Total Cash Per Share (mrq) | 0.002 USD |
| Total Debt (mrq) | 15.77M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.125 |
| Book Value Per Share (mrq) | -0.04314464 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -46000 USD |
| Levered Free Cash Flow (ttm) | -381375 USD |
Profile of Proteome Sciences
| Country | United States |
| State | N/A |
| City | Cobham |
| Address | Coveham House |
| ZIP | KT11 3EP |
| Phone | 44 20 7043 2116 |
| Website | https://www.proteomics.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 32 |
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant that provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator which analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids. It also offers top 14 and super depletion of proteins from serum and plasma; selective reaction monitoring (SRM) and parallel reaction monitoring (PRM); SRM assay, a targeted mass spectrometry assay format for the routine measurement of biomarkers; and TMT SRM, a targeted assay format that enables the rapid validation of biomarker candidates. The company serves its products to pharmaceutical and biotechnology companies, as well as to academic research institutes. Proteome Sciences plc was incorporated in 1993 and is based in Cobham, the United Kingdom.
Q&A For Proteome Sciences Stock
What is a current PMSNF stock price?
Proteome Sciences PMSNF stock price today per share is 0.0100 USD.
How to purchase Proteome Sciences stock?
You can buy PMSNF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Proteome Sciences?
The stock symbol or ticker of Proteome Sciences is PMSNF.
Which industry does the Proteome Sciences company belong to?
The Proteome Sciences industry is Diagnostics & Research.
How many shares does Proteome Sciences have in circulation?
The max supply of Proteome Sciences shares is 350.72M.
What is Proteome Sciences Price to Earnings Ratio (PE Ratio)?
Proteome Sciences PE Ratio is now.
What was Proteome Sciences earnings per share over the trailing 12 months (TTM)?
Proteome Sciences EPS is -0.01 USD over the trailing 12 months.
Which sector does the Proteome Sciences company belong to?
The Proteome Sciences sector is Healthcare.
